Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 7/2012

Open Access 01-07-2012 | Article

bla KPC and rmtB on a single plasmid in Enterobacter amnigenus and Klebsiella pneumoniae isolates from the same patient

Authors: J.-F. Sheng, J.-J. Li, S. Tu, Z.-K. Sheng, S. Bi, M.-H. Zhu, X.-M. Shen, L.-J. Li

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 7/2012

Login to get access

Abstract

Enterobacter amnigenus (EA76) and Klebsiella pneumoniae (KP76) isolates with multidrug-resistant (MDR) patterns were identified from the same patient in the neurosurgery department of our hospital. An outbreak of MDR K. pneumoniae had also occurred in this department. To characterize the resistance mechanism and molecular epidemiology of these isolates, sequential experiments including antimicrobial susceptibility testing, polymerase chain reaction (PCR), plasmid analysis, pulsed field gel electrophoresis (PFGE), and multilocus sequence typing (MLST) were performed. EA76 and KP76 were resistant to all of the antibiotics tested, except colistin and tigecycline. bla KPC-2, bla TEM-1, bla SHV-12, bla CTX-M-3, bla CTX-M-14, and rmtB genes were identified in both isolates, with bla KPC-2, bla TEM-1, bla CTX-M-14, and rmtB being co-carried on one plasmid in each isolate. Further analysis showed different restriction patterns between the two KPC-carrying plasmids. Of the 11 carbapenem-resistant isolates found in the outbreak, all were resistant to all of the β-lactams tested, with 63.64% (7/11) also exhibiting resistance to aminoglycosides and 72.73% (8/11) exhibiting resistance to quinolones. PCR analysis and molecular typing of the 11 K. pneumoniae strains revealed that the seven aminoglycoside-resistant isolates shared the same antibiotic-resistant gene pattern and identical or one-band-difference PFGE profiles relative to KP76. In addition, all of the eight aminoglycoside-resistant isolates, including KP76, belonged to the national epidemic clone ST11. The overall results indicate the emergence of E. amnigenus and outbreak of ST11 K. pneumoniae, with both co-harboring bla KPC and rmtB genes on a single plasmid in our neurosurgery wards.
Literature
1.
go back to reference Nordmann P, Cuzon G, Naas T (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:228–236PubMedCrossRef Nordmann P, Cuzon G, Naas T (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:228–236PubMedCrossRef
2.
go back to reference Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC (2001) Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151–1161PubMedCrossRef Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC (2001) Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151–1161PubMedCrossRef
3.
go back to reference Giakkoupi P, Papagiannitsis CC, Miriagou V, Pappa O, Polemis M, Tryfinopoulou K, Tzouvelekis LS, Vatopoulos AC (2011) An update of the evolving epidemic of bla KPC-2-carrying Klebsiella pneumoniae in Greece (2009–10). J Antimicrob Chemother 66:1510–1513PubMedCrossRef Giakkoupi P, Papagiannitsis CC, Miriagou V, Pappa O, Polemis M, Tryfinopoulou K, Tzouvelekis LS, Vatopoulos AC (2011) An update of the evolving epidemic of bla KPC-2-carrying Klebsiella pneumoniae in Greece (2009–10). J Antimicrob Chemother 66:1510–1513PubMedCrossRef
4.
go back to reference Souli M, Galani I, Antoniadou A, Papadomichelakis E, Poulakou G, Panagea T, Vourli S, Zerva L, Armaganidis A, Kanellakopoulou K, Giamarellou H (2010) An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 50:364–373PubMedCrossRef Souli M, Galani I, Antoniadou A, Papadomichelakis E, Poulakou G, Panagea T, Vourli S, Zerva L, Armaganidis A, Kanellakopoulou K, Giamarellou H (2010) An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 50:364–373PubMedCrossRef
5.
go back to reference Doi Y, Arakawa Y (2007) 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 45:88–94PubMedCrossRef Doi Y, Arakawa Y (2007) 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 45:88–94PubMedCrossRef
6.
go back to reference Wachino J, Shibayama K, Kurokawa H, Kimura K, Yamane K, Suzuki S, Shibata N, Ike Y, Arakawa Y (2007) Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides. Antimicrob Agents Chemother 51:4401–4409PubMedCrossRef Wachino J, Shibayama K, Kurokawa H, Kimura K, Yamane K, Suzuki S, Shibata N, Ike Y, Arakawa Y (2007) Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides. Antimicrob Agents Chemother 51:4401–4409PubMedCrossRef
7.
go back to reference Zhou Y, Yu H, Guo Q, Xu X, Ye X, Wu S, Guo Y, Wang M (2010) Distribution of 16S rRNA methylases among different species of Gram-negative bacilli with high-level resistance to aminoglycosides. Eur J Clin Microbiol Infect Dis 29:1349–1353PubMedCrossRef Zhou Y, Yu H, Guo Q, Xu X, Ye X, Wu S, Guo Y, Wang M (2010) Distribution of 16S rRNA methylases among different species of Gram-negative bacilli with high-level resistance to aminoglycosides. Eur J Clin Microbiol Infect Dis 29:1349–1353PubMedCrossRef
8.
go back to reference Zacharczuk K, Piekarska K, Szych J, Zawidzka E, Sulikowska A, Wardak S, Jagielski M, Gierczynski R (2011) Emergence of Klebsiella pneumoniae coproducing KPC-2 and 16S rRNA methylase ArmA in Poland. Antimicrob Agents Chemother 55:443–446PubMedCrossRef Zacharczuk K, Piekarska K, Szych J, Zawidzka E, Sulikowska A, Wardak S, Jagielski M, Gierczynski R (2011) Emergence of Klebsiella pneumoniae coproducing KPC-2 and 16S rRNA methylase ArmA in Poland. Antimicrob Agents Chemother 55:443–446PubMedCrossRef
9.
go back to reference Wu Q, Liu Q, Han L, Sun J, Ni Y (2010) Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 and ArmA 16S rRNA methylase conferring high-level aminoglycoside resistance in carbapenem-resistant Enterobacter cloacae in China. Diagn Microbiol Infect Dis 66:326–328PubMedCrossRef Wu Q, Liu Q, Han L, Sun J, Ni Y (2010) Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 and ArmA 16S rRNA methylase conferring high-level aminoglycoside resistance in carbapenem-resistant Enterobacter cloacae in China. Diagn Microbiol Infect Dis 66:326–328PubMedCrossRef
10.
go back to reference Jiang Y, Yu D, Wei Z, Shen P, Zhou Z, Yu Y (2010) Complete nucleotide sequence of Klebsiella pneumoniae multidrug resistance plasmid pKP048, carrying bla KPC-2, bla DHA-1, qnrB4, and armA. Antimicrob Agents Chemother 54:3967–3969PubMedCrossRef Jiang Y, Yu D, Wei Z, Shen P, Zhou Z, Yu Y (2010) Complete nucleotide sequence of Klebsiella pneumoniae multidrug resistance plasmid pKP048, carrying bla KPC-2, bla DHA-1, qnrB4, and armA. Antimicrob Agents Chemother 54:3967–3969PubMedCrossRef
11.
go back to reference Clinical Laboratory and Standards Institute (CLSI) (2010) Performance Standards for Antimicrobial Susceptibility Testing: M100-S20-U. CLSI, Wayne, PA, USA Clinical Laboratory and Standards Institute (CLSI) (2010) Performance Standards for Antimicrobial Susceptibility Testing: M100-S20-U. CLSI, Wayne, PA, USA
12.
go back to reference Gales AC, Reis AO, Jones RN (2001) Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39:183–190PubMedCrossRef Gales AC, Reis AO, Jones RN (2001) Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39:183–190PubMedCrossRef
13.
go back to reference Yu FY, Yao D, Pan JY, Chen C, Qin ZQ, Parsons C, Yang LH, Li QQ, Zhang XQ, Qu D, Wang LX (2010) High prevalence of plasmid-mediated 16S rRNA methylase gene rmtB among Escherichia coli clinical isolates from a Chinese teaching hospital. BMC Infect Dis 10:184PubMedCrossRef Yu FY, Yao D, Pan JY, Chen C, Qin ZQ, Parsons C, Yang LH, Li QQ, Zhang XQ, Qu D, Wang LX (2010) High prevalence of plasmid-mediated 16S rRNA methylase gene rmtB among Escherichia coli clinical isolates from a Chinese teaching hospital. BMC Infect Dis 10:184PubMedCrossRef
14.
go back to reference Yamane K, Wachino J, Doi Y, Kurokawa H, Arakawa Y (2005) Global spread of multiple aminoglycoside resistance genes. Emerg Infect Dis 11:951–953PubMedCrossRef Yamane K, Wachino J, Doi Y, Kurokawa H, Arakawa Y (2005) Global spread of multiple aminoglycoside resistance genes. Emerg Infect Dis 11:951–953PubMedCrossRef
15.
go back to reference Navon-Venezia S, Chmelnitsky I, Leavitt A, Carmeli Y (2008) Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in proteus mirabilis in Israel. J Antimicrob Chemother 62:289–295PubMedCrossRef Navon-Venezia S, Chmelnitsky I, Leavitt A, Carmeli Y (2008) Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in proteus mirabilis in Israel. J Antimicrob Chemother 62:289–295PubMedCrossRef
16.
go back to reference Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P (2007) Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 60:394–397PubMedCrossRef Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P (2007) Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 60:394–397PubMedCrossRef
17.
go back to reference Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239PubMed Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239PubMed
18.
go back to reference Corti G, Mondanelli N, Losco M, Bartolini L, Fontanelli A, Paradisi F (2009) Post-traumatic infection of the lower limb caused by rare Enterobacteriaceae and Mucorales in a young healthy male. Int J Infect Dis 13:e57–e60PubMedCrossRef Corti G, Mondanelli N, Losco M, Bartolini L, Fontanelli A, Paradisi F (2009) Post-traumatic infection of the lower limb caused by rare Enterobacteriaceae and Mucorales in a young healthy male. Int J Infect Dis 13:e57–e60PubMedCrossRef
19.
go back to reference Korah S, Braganza A, Jacob P, Balaji V (2007) An “epidemic” of post cataract surgery endophthalmitis by a new organism. Indian J Ophthalmol 55:464–466PubMedCrossRef Korah S, Braganza A, Jacob P, Balaji V (2007) An “epidemic” of post cataract surgery endophthalmitis by a new organism. Indian J Ophthalmol 55:464–466PubMedCrossRef
20.
go back to reference Stock I, Wiedemann B (2002) Natural antibiotic susceptibility of Enterobacter amnigenus, Enterobacter cancerogenus, Enterobacter gergoviae and Enterobacter sakazakii strains. Clin Microbiol Infect 8:564–578PubMedCrossRef Stock I, Wiedemann B (2002) Natural antibiotic susceptibility of Enterobacter amnigenus, Enterobacter cancerogenus, Enterobacter gergoviae and Enterobacter sakazakii strains. Clin Microbiol Infect 8:564–578PubMedCrossRef
21.
go back to reference Goren MG, Carmeli Y, Schwaber MJ, Chmelnitsky I, Schechner V, Navon-Venezia S (2010) Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient. Emerg Infect Dis 16:1014–1017PubMed Goren MG, Carmeli Y, Schwaber MJ, Chmelnitsky I, Schechner V, Navon-Venezia S (2010) Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient. Emerg Infect Dis 16:1014–1017PubMed
22.
go back to reference Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y (2011) ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother 66:307–312PubMedCrossRef Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y (2011) ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother 66:307–312PubMedCrossRef
Metadata
Title
bla KPC and rmtB on a single plasmid in Enterobacter amnigenus and Klebsiella pneumoniae isolates from the same patient
Authors
J.-F. Sheng
J.-J. Li
S. Tu
Z.-K. Sheng
S. Bi
M.-H. Zhu
X.-M. Shen
L.-J. Li
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 7/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1481-x

Other articles of this Issue 7/2012

European Journal of Clinical Microbiology & Infectious Diseases 7/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine